Anstee QM et al. and others confirmed that loss-of-function variations in HSD17B13 rs9992651 G>A have been linked to the protective effect against NAFLD generally [18,21]. This evidence concerns the gene HSD17B13 and metabolic dysfunction-associated steatotic liver disease.